
DIM · Sartorius Stedim Biotech SA
208.00
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro21.30B
PE
76.90
EV/EBITDA
26.1
DIV Yield
0.3%
Payout Ratio
25%
MQV Rating
4Weak
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO All
- HALO Dividend Growth
- Recent Price upgrade
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
-71.30%
EBITDA Margin
29.20%
Operating Cashflow
€539m
Free Cash Flow Return
8.30%
ROIC
4.10%
Interest Coverage
5.70
Quick Ratio
0.50
Performance
52 weeks range
Low 150 - 225
Trade Value (12mth)
US$4,544,149.00
1 week
2.82%
1 month
14.8%
YTD
5.09%
1 year
19.66%
All time high
551.00
Additional Data
Shares Outstanding (Fully Diluted)
97m
HALO Sector
Healthcare
Next Company Report Date
28-Jan-27
Next Ex Dividend Date
31-Mar-26
Next Dividend Pay Date
02-Apr-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Strong
Dividends
Very Strong
Quality
Capital Efficiency
Neutral
Balance Sheet
Weak
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Sartorius AG | Public Company |
| Sartorius Stedim Biotech SA | Public Company |